glp-1 alzheimer's study Frontiers π§Will GLP-1RA drugs be the
Description
They work by mimicking a natural hormone in the body that regulates blood sugar, appetite, and digestion
FDA approval is anticipated in late 2026
doi: 10.3390/nu11122949
A scoping review published in 2025 in the journal Cureus noted an increasing number of reports of people losing hair while being treated with tirzepatide, dulaglutide and semaglutide
Accessed March 9, 2026.
Exp Mol Med 2022;54:37792
